Alzamend Neuro Inc (ALZN) — Net Asset Momentum
Alzamend Neuro Inc (ALZN) recorded a net asset momentum of -81.5% as of April 2026, with net assets of $733.21K USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See ALZN book value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Alzamend Neuro Inc Net Asset Momentum (2016–2026)
This chart tracks Alzamend Neuro Inc's year-over-year net asset growth across 11 annual reporting periods from 2016 to 2026. The most recent momentum reading is -81.5%, with net assets of $733.21K USD as of April 2026. For live market cap and overall valuation, see Alzamend Neuro Inc market cap and net worth.
Annual Net Asset History for Alzamend Neuro Inc (2016–2026)
The table below shows the complete annual net asset history for Alzamend Neuro Inc from 2016 to 2026, covering 11 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check tangible net worth ratio of Alzamend Neuro Inc to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2026 | $733.21K | $2.08 Million | $1.35 Million | ▼ -81.5% |
| 2025 | $3.97 Million | $4.60 Million | $634.76K | ▲ +253.0% |
| 2024 | $-2.59 Million | $631.59K | $3.23 Million | ▼ -185.2% |
| 2023 | $3.05 Million | $5.92 Million | $2.87 Million | ▼ -77.2% |
| 2022 | $13.35 Million | $14.52 Million | $1.16 Million | ▲ +563.3% |
| 2021 | $2.01 Million | $2.91 Million | $899.64K | ▲ +145.0% |
| 2020 | $821.71K | $1.81 Million | $992.31K | ▲ +159.3% |
| 2019 | $316.92K | $1.50 Million | $1.18 Million | ▼ -86.3% |
| 2018 | $2.32 Million | $2.42 Million | $96.72K | ▲ +496.5% |
| 2017 | $-584.93K | $132.29K | $717.22K | ▼ -551720.8% |
| 2016 | $-106.00 | $30.61K | $30.72K | — |